Pharmacology of serotonin antagonists

Author(s):  
Jacob Nouriel ◽  
Gildasio De Oliveira ◽  
Henrik Kehlet
1998 ◽  
Vol 6 (2) ◽  
pp. 133-135
Author(s):  
RD Harvey 3rd ◽  
CL Lindley

1987 ◽  
Vol 30 (10) ◽  
pp. 1823-1826 ◽  
Author(s):  
Gifford Marzoni ◽  
William L. Garbrecht ◽  
Pawel Fludzinski ◽  
Marlene L. Cohen

1979 ◽  
Vol 35 (11) ◽  
pp. 1532-1534 ◽  
Author(s):  
K. Rácz ◽  
I. Wolf ◽  
R. Kiss ◽  
Gy. Lada ◽  
S. Vida ◽  
...  

1993 ◽  
Vol 15 (2-3) ◽  
pp. 243-250 ◽  
Author(s):  
L. Bondesson ◽  
K. Nordlind ◽  
S. Lidén ◽  
E. Sundström

Development ◽  
1979 ◽  
Vol 53 (1) ◽  
pp. 75-90
Author(s):  
Elizabeth L. Wee ◽  
Bruce S. Babiarz ◽  
Stephen Zimmerman ◽  
Ernest F. Zimmerman

Previous studies have localized non-muscle contractile systems in the posterior (region 2) and the anterior (region 3) ends of mouse palates at the time of shelf movement. In order to determine whether these contractile systems function in shelf rotation, effects of pharmacologic agents have been analyzed in embryo culture. First, it was shown that the posterior end of the palate rotates before the anterior end, and its rotation in culture was proportionally greater as development of the embryo progressed. Generally, the posterior end of the palate was more easily inhibited in embryo culture than the anterior end. Serotonin at 10–−8 M to 10–−5 M was shown to significantly stimulate rotation atthe anterior end of the palate after 2 h in embryo culture. The effect on the posterior palate was less pronounced. To investigate further the role of this neurotransmitter on palate shelf rotation, serotonin antagonists were employed. Methysergide (10–−4 M) inhibited anterior shelf rotation to 12% of control values (P < 0·005), while not significantly affecting the posterior end. Ergotamine (10–−6 M) significantly inhibited the stimulation induced by 10–−5 M serotonin (P < 0·025). Cyproheptadine (10–−9 M) partially inhibited anterior and posterior shelf rotation in embryo culture. When injected into the pregnant dam, cyproheptadine partially inhibited shelf rotation and fusion. The palate was examined histologically after embryo culture. In the presence of 10–−4 M methysergide, the elongated contractile cells in region 3 at the anterior and midpalatal mesenchyme were prevented from rounding. Thus, serotonin may be regulating rotation of the anterior end of the palate by an effect on a cell-mediated process.


Author(s):  
Becky L. Kinkead ◽  
Michael J. Owens ◽  
Charles B. Nemeroff

1977 ◽  
Author(s):  
A.H. Drummond ◽  
H.J. Olverman ◽  
D.E. MacIntyre ◽  
J.L. Gordon

Serotonin and dopamine are transported by platelets, and serotonin also stimulates platelets to change shape. Km values for transport are around 1 µM for serotonin and 40 μM for dopamine. Both amines also enter platelets by diffusion. Antidepressant drugs (e.g. chlorimipramine; Lilly 110140) inhibit serotonin and dopamine uptake with equal potency and also block the stimulatory action of serotonin, but serotonin antagonists (e.g. methysergide; d-lysergic acid diethylamide) which are potent inhibitors of the serotonin-induced shape-change do not affect the transport of serotonin or dopamine. Binding studies with [3H]-serotonin show heterogeneity of receptors: one site has characteristics consistent with the uptake carrier, and another is selectively blocked by serotonin antagonists. We conclude that dopamine is transported into platelets by the serotonin carrier (although with a much lower affinity) and that a separate site mediates platelet stimulation by serotonin. The concept of platelets as models for aminergic neurons in the central nervous system may be valid for serotonin but does not hold for dopamine.


Sign in / Sign up

Export Citation Format

Share Document